
201 - 500 Mitarbeiter
Gegründet 2017
🧬 Biotechnologie
💊 Pharmazie
🏥 Gesundheitswesen
💰 €125.000.000 Post-IPO Equity - Stoke Therapeutics im 2024-03
Biotechnology • Pharmaceuticals • Healthcare
Stoke Therapeutics ist ein Biotechnologieunternehmen, das RNA-basierte Therapeutika entwickelt, um die Proteinproduktion aus den eigenen Genen eines Patienten zu erhöhen und seltene genetische Erkrankungen zu behandeln. Die TANGO-Plattform (Targeted Augmentation of Nuclear Gene Output) verwendet Antisense-Oligonukleotide zur Hochregulierung der Genexpression bei Haploinsuffizienzstörungen. Zu den führenden Programmen gehören STK-001, eine sich in der Entwicklung befindliche Antisense-Therapie für das Dravet-Syndrom (SCN1A Haploinsuffizienz), sowie weitere Programme, die sich auf genetische Neurologie und seltene Krankheitsindikationen konzentrieren.
🕒 vor 12 Tagen
🗣️🇺🇸🇬🇧 Englisch erforderlich
Woher diese Stelle stammt
Veröffentlicht auf der Karriereseite von Stoke Therapeutics, nicht über eine Jobbörse
Von Remote Rocketship zum ersten Mal gesehen vor 12 Tagen
Noch offen auf der Website von Stoke Therapeutics. Geprüft vor 3 Stunden.

201 - 500 Mitarbeiter
Gegründet 2017
🧬 Biotechnologie
💊 Pharmazie
🏥 Gesundheitswesen
💰 €125.000.000 Post-IPO Equity - Stoke Therapeutics im 2024-03
Biotechnology • Pharmaceuticals • Healthcare
Stoke Therapeutics ist ein Biotechnologieunternehmen, das RNA-basierte Therapeutika entwickelt, um die Proteinproduktion aus den eigenen Genen eines Patienten zu erhöhen und seltene genetische Erkrankungen zu behandeln. Die TANGO-Plattform (Targeted Augmentation of Nuclear Gene Output) verwendet Antisense-Oligonukleotide zur Hochregulierung der Genexpression bei Haploinsuffizienzstörungen. Zu den führenden Programmen gehören STK-001, eine sich in der Entwicklung befindliche Antisense-Therapie für das Dravet-Syndrom (SCN1A Haploinsuffizienz), sowie weitere Programme, die sich auf genetische Neurologie und seltene Krankheitsindikationen konzentrieren.
• Serve as the primary relationship owner for all accounts in the region • Lead and execute Stoke’s payer access strategy from the ground up • Engage targeted accounts and policy decision-makers to advance coverage timelines • Establish Stoke’s credibility and share clinical data with medical benefit policy decision-makers • Develop and execute pre-launch and launch-phase access strategies • Serve as strategic leader for key accounts in the region • Develop account-specific action plans to shorten the timeline from FDA approval to positive coverage determination • Build payer relationships before NDA submission • Develop multi-year access plans anticipating commercial cycles and competitive coverage shifts • Educate payers on clinical evidence, FDA labeling, treatment guidelines, and health-economic data • Monitor medical policy language and partner with Medical Affairs, HEOR, and Advocacy • Engage payer Medical Directors to obtain guidance letters or billing instructions pending permanent J code assignment • Influence policy decision-makers to achieve desired coverage outcomes • Serve as subject-matter expert on buy-and-bill reimbursement for miscellaneous J codes • Educate payer medical policy teams on claims submission, billing units, and NDC-to-J code crosswalks • Drive alignment across commercial and field medical teams and cross-functional departments • Coordinate field reimbursement and patient services to support approval success and timely patient access • Engage the Dravet syndrome patient and caregiver community • Conduct payer engagements in compliance with company SOPs, OIG guidelines, PhRMA Code, and applicable regulations • Navigate access challenges for a first-in-class disease-modifying ASO therapy
• Bachelor’s degree required; advanced degree (MBA, MPH, PharmD) preferred • 15+ years in pharma/biotech • Minimum 10 years in payer account management with lead responsibility for one of the three large PBM and National accounts • Proven track record of achieving positive coverage outcomes for orphan designation or rare disease products on the medical benefit • Pre-launch payer strategy experience • Hands-on experience navigating a miscellaneous J code (J3490/J3590) environment, including transition to a permanent product-specific code • Strong command of managed care economics, formulary management, utilization management, and coverage policy development processes at national payers • Rare pediatric or neurological disease product launch experience; CNS or epilepsy payer experience a significant differentiator • Familiarity with disease-modifying therapy and gene testing reimbursement pathways as established according to payer policy • Experience at a startup or early commercial-stage biotech building its commercial infrastructure for the first time • Exceptional ability to influence across functions without direct authority • Passion for patient access and rare-disease impact • Proximity to a major US airport preferred • Approximately 50% travel
• Annual bonus • Equity participation • Medical insurance • Dental insurance • Vision insurance • Life insurance • Long- and short-term disability insurance • Paid parental leave • 401K plan with company match • Unlimited vacation time • Tuition assistance • Employee Stock Purchase Program (ESPP) • Flexible work arrangements • Employee-led Diversity, Inclusion, and Belonging (DIB) Committee
Jetzt BewerbenVerbessern Sie Ihre Chancen auf ein Vorstellungsgespräch, indem Sie Ihre Lebenslauf-Bewertung vor der Bewerbung überprüfen.
🕒 vor 12 Tagen
Director leading enterprise learning practice, executive advisory, and pipeline growth for Panopto’s video knowledge platform. Partnering with sales and product teams across Fortune 500 accounts.
🇺🇸 Vereinigte Staaten – Remote
💵 $160.000 - $200.000 / Jahr
💰 Private Equity Round im 2021-04
⏰ Vollzeit
🟠 Senior
👔 Direktor
🦅 H1B-Visum-Sponsor
🗣️🇺🇸🇬🇧 Englisch erforderlich
🕒 vor 12 Tagen
Higher education practice leader driving Panopto’s video technology growth and institutional adoption. Advising campus executives and shaping go-to-market strategy for academic video technology.
🇺🇸 Vereinigte Staaten – Remote
💵 $160.000 - $200.000 / Jahr
💰 Private Equity Round im 2021-04
⏰ Vollzeit
🟠 Senior
👔 Direktor
🦅 H1B-Visum-Sponsor
🗣️🇺🇸🇬🇧 Englisch erforderlich
🕒 vor 12 Tagen
Senior Director of Talent booking instructors and leading talent acquisition and relations for MasterClass’s streaming education platform. Negotiating high-profile talent deals across classes, podcasts, events, and certificate programs.
🇺🇸 Vereinigte Staaten – Remote
💵 $183.000 - $220.000 / Jahr
⏰ Vollzeit
🟠 Senior
👔 Direktor
🦅 H1B-Visum-Sponsor
🗣️🇺🇸🇬🇧 Englisch erforderlich
🕒 vor 12 Tagen
Regeneron oncology liaison engaging U.S. thought leaders across a multi-state territory. Translating insights into pharmaceutical marketing strategy for NSCLC and solid-tumor therapies.
🇺🇸 Vereinigte Staaten – Remote
💵 $157.200 - $256.600 / Jahr
💰 Post-IPO Equity im 2023-10
⏰ Vollzeit
🟠 Senior
👔 Direktor
🦅 H1B-Visum-Sponsor
🗣️🇺🇸🇬🇧 Englisch erforderlich
🕒 vor 12 Tagen
Associate Director developing CME grants, scientific content, and outcomes research for PRIME Education. Designing continuing education programs for interprofessional healthcare teams.
🇺🇸 Vereinigte Staaten – Remote
💰 €650.000.000 Post-IPO Debt im 2017-06
⏰ Vollzeit
🟠 Senior
👔 Direktor
🦅 H1B-Visum-Sponsor
🗣️🇺🇸🇬🇧 Englisch erforderlich